Q3 2017 13F Holders as of 9/30/2017
-
Type / Class
-
Equity / COM NEW
-
Number of holders
-
40
-
Total 13F shares, excl. options
-
3.29M
-
Shares change
-
-550K
-
Total reported value, excl. options
-
$14.2M
-
Value change
-
-$2.11M
-
Number of buys
-
19
-
Number of sells
-
-22
-
Price
-
$4.30
Significant Holders of Niagen Bioscience, Inc. - COM NEW (NAGE) as of Q3 2017
53 filings reported holding NAGE - Niagen Bioscience, Inc. - COM NEW as of Q3 2017.
Niagen Bioscience, Inc. - COM NEW (NAGE) has 40 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 3.29M shares
.
Largest 10 shareholders include VANGUARD GROUP INC (979K shares), Tieton Capital Management, LLC (591K shares), MILLENNIUM MANAGEMENT LLC (337K shares), Granite Investment Partners, LLC (250K shares), North Star Investment Management Corp. (239K shares), GEODE CAPITAL MANAGEMENT, LLC (175K shares), BlackRock Inc. (101K shares), Virtu Financial LLC (63.2K shares), Arete Wealth Advisors, LLC (62.6K shares), and D.A. DAVIDSON & CO. (43K shares).
This table shows the top 40 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.